Our data in the present study suggest that alveolar IL-6 has no role in the pathogenesis nor protection against lung inflammation in AKI given that BAL fluid IL-6 was not increased in AKI, and administration of IT IL-6 had no effect on lung inflammation in AKI. This evidence concerns the gene IL6 and acute kidney injury.